Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Acta Diabetologica
Literature
1.
Sackett DL, Richardson WF, Rosenberg W, Haynes RB (1997) Evidence-based medicine. How to produce and teach EBM. Churchill. Livingstone, New York
2.
Sackett DL, Haynes RB, Guyatt GH, Tugwell P (1991) Clinical epidemiology:a basic science for clinical medicine, 2nd edn. Little, Brown and Thomas, Boston
3.
Sackett DL, Wennberg JE (1997) Choosing the best research design for each question (editorial). Br Med J 315:1636
4.
Diabete Italia, AMD Associazione Medici Diabetologi, SID Sociétà Italiana di Diabetologia (2008) Italian standards for diabetes mellitus 2007: executive summary. Acta Diabetol 45:107–127
5.
International Diabetes Federation (2003) Guide for guidelines: a guide for clinical guideline development. IDF, Brussels
6.
Webster’s third new international dictionary (1976) Merriam Co., Springfield
7.
International Diabetes Federation (2005) Global guideline for type 2 diabetes. International Diabetes Federation, Brussels
8.
World Health Organization (2003) Adherence to long-term therapies: evidence for action. World Health Organization, Geneva
Metadata
Title
Standards, guidelines and the practice of medicine
Author
Pierre Lefèbvre
Publication date
01-12-2008
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 4/2008
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-008-0059-2

Other articles of this Issue 4/2008

Acta Diabetologica 4/2008 Go to the issue

Original Article

The role of new basal insulin analogues in the initiation and optimisation of insulin therapy in type 2 diabetes

Original Article

Negative effect of leptin on bone mass in type 1 diabetes

Original Article

Temporal trends of HLA genotype frequencies of type 1 diabetes patients in Sweden from 1986 to 2005 suggest altered risk

Original Article

Analysis of the 2004–2007 literature on therapeutic patient education in diabetes: results and trends

Original Article

Attenuation of streptozotocin-induced oxidative stress in hepatic and intestinal tissues of wistar rat by methanolic-garlic extract

Original Article

Sleep abnormalities in type 2 diabetes may be associated with glycemic control
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits